Literature DB >> 8081703

Alteration in length of telomeric repeats in lung cancer.

Y Shirotani1, K Hiyama, S Ishioka, K Inyaku, Y Awaya, S Yonehara, Y Yoshida, K Inai, E Hiyama, K Hasegawa.   

Abstract

We investigated the relationship between telomere length and various characteristics of tumor cells in 46 lung cancer specimens (40 primary lesions and six metastatic lesions). Three variant patterns of telomere length were observed in 16 cases (34.8%): reduction in 13 cases, elongation in two cases, and convergence in one case. These variant patterns were frequently observed in small cell carcinomas, in metastatic lesions, and in cases which possessed the S-type allele of the L-myc gene. All three cases with telomere elongation or convergence were associated with a poor prognosis. This is compatible with the previous report suggesting that telomerase activity may be an indicator of immortality in vitro. In adenocarcinoma, telomere reduction or elongation was also observed in the early stages with a low percentage of cells in the S-phase, while in cases with other histologic types, these changes were observed only in late stage, in metastatic lesions, or in cancerous tissues with a high percentage of cells in the S-phase. Although the reduction of telomere length in these tissues may be a result of many cell divisions, it may represent another stage of carcinogenesis in early-stage adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8081703     DOI: 10.1016/0169-5002(94)90280-1

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  4 in total

1.  miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells.

Authors:  Ke Jin; Yonghua Xiang; Jing Tang; Guangchun Wu; Junwei Li; Huaichun Xiao; Chunwang Li; Yuxiang Chen; Jingfeng Zhao
Journal:  Tumour Biol       Date:  2014-02

2.  Leukocyte telomere length: a novel biomarker to predict the prognosis of glioma patients.

Authors:  Yibing Chen; Yousheng Wu; Xiaojun Huang; Ping Qu; Gang Li; Tianbo Jin; Jinliang Xing; Shiming He
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-22       Impact factor: 4.553

3.  ALTernative Telomere Maintenance and Cancer.

Authors:  Robert L Dilley; Roger A Greenberg
Journal:  Trends Cancer       Date:  2015-10-01

4.  Potential clinical role of telomere length in human glioblastoma.

Authors:  D La Torre; M Aguennouz; A Conti; M Giusa; G Raffa; R V Abbritti; A Germano'; F F Angileri
Journal:  Transl Med UniSa       Date:  2011-10-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.